As of April 25, HHS/ASPR established threshold levels for ordering COVID-19 therapeutics available to each jurisdiction. From April 25, 2022 to September 6, 2022 available therapeutics included: Paxlovid, Lagevrio, bebtelovimab, and Evusheld (see the table below for threshold values). The table below is available for archival purposes only.
To find out how HHS/ASPR is currently bringing COVID-19 therapeutics to your state or territory, see
COVID-19 Therapeutics Thresholds, Orders, and Replenishment by Jurisdiction.
COVID-19 Therapeutics Threshold Determinations
April 25, 2022 – September 6, 2022
|
|
Paxlovid
(Standard and Renal) |
Lagevrio
(molnupiravir) |
Bebtelovimab |
Evusheld |
Total |
|
September 6, 2022: Bebtelovimab Final Allocation |
- |
- |
19,500 |
- |
19,500 |
|
August 29-September 4, 2022 |
613,580 |
92,352 |
0 |
203,736 |
909,668 |
|
August 22-August 28, 2022 |
612,060 |
91,920 |
21,915 |
0 |
725,895 |
|
August 15-August 21, 2022 |
612,060 |
91,920 |
29,060 |
0 |
733,040 |
|
August 8-August 14, 2022 |
612,060 |
91,896 |
29,110 |
0 |
733,066 |
|
August 1-August 7, 2022 |
612,260 |
92,328 |
29,760 |
203,760 |
938,108 |
|
July 25-July 31, 2022 |
610,340 |
91,896 |
29,190 |
0 |
731,426 |
|
July 18-July 24, 2022 |
642,695 |
113,368 |
29,250 |
0 |
785,313 |
|
July 11-July 17, 2022 |
596,955 |
114,400 |
29,200 |
0 |
740,555 |
|
July 4-July 10, 2022 |
575,715 |
114,856 |
29,210 |
0 |
719,781 |
|
June 27-July 3, 2022 |
590,085 |
114,576 |
28,710 |
201,168 |
934,539 |
|
June 20-June 26, 2022 |
579,120 |
109,896 |
28,985 |
0 |
718,001 |
|
June 13-June 19, 2022 |
405,084 |
71,664 |
29,060 |
0 |
505,808 |
|
June 6-June 12, 2022 |
444,225 |
92,828 |
29,140 |
240 |
566,433 |
|
May 30-June 5, 2022 |
459,638 |
100,820 |
29,630 |
200,808 |
790,896 |
|
May 23-May 29, 2022 |
473,106 |
115,960 |
29,100 |
0 |
618,166 |
|
May 16-May 22, 2022 |
463,417 |
105,036 |
29,040 |
0 |
597,493 |
|
May 9-May 15, 2022 |
386,965
|
107,208 |
29,110 |
0 |
523,283 |
|
May 2-May 8, 2022 |
348,160 |
108,920 |
29,000 |
199,992 |
686,072 |
|
April 25-May 1, 2022 |
386,700 |
177,120 |
30,000 |
0 |
593,820 |
Other Prior COVID-19 Therapeutic Product Distribution Efforts
